๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanoma

โœ Scribed by DONALD L. MORTON; DAVE S. B. HOON; J. ANNE NIZZE; LELAND J. FOSHAG; ESTELA FAMATIGA; LESLIE A. WANEK; CINDY CHANG; REIKO F. IRIE; RISHAB K. GUPTA; ROBERT ELASHOFF

Book ID
119869520
Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
885 KB
Volume
690
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of patients with progressive u
Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine
โœ Ramon Vilella; Daniel Benitez; Jordi Milร ; Antoni Vilalta; Ramon Rull; Francisco ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 170 KB

## Abstract Unresectable metastatic melanoma has no elective treatment. Neither chemotherapy, intravenous ILโ€2 nor biochemotherapy clearly improves the overall survival. Recent assays with therapeutic vaccines have been recently yielded promising results. Here, we describe the application, clinical

Active specific immunotherapy with polyv
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases
โœ Eddy C. Hsueh; Larry Nathanson; Leland J. Foshag; Richard Essner; J. Anne Nizze; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 341 KB ๐Ÿ‘ 2 views

## BACKGROUND. This study was conducted to document the rate, duration, and type of objective response to active specific immunotherapy with a polyvalent melanoma cell vaccine (PMCV) for patients with in-transit melanoma metastases and to identify any acute or chronic toxic effects of PMCV treatme